GLOW 70mg brings together GHK‑Cu 50mg, BPC‑157 10mg, and TB500 10mg for researchers interested in how copper tripeptides, gastric-derived peptides, and thymosin beta‑4 fragments interact within the same system. This fixed combination supports exploration of extracellular matrix signalling, migration behaviour, and vascular pathways under unified conditions.

The 70mg total content offers ample material for staged experiments - single-exposure, time‑course, and comparative runs versus individual constituents. Many teams use GLOW alongside our single-ingredient vials when they want to dissect contribution from each pathway while keeping supply source constant.

Provided as a research-only blend, with COA and batch data available from Ascend Labs on request.

Disclaimer: Not for human or animal consumption. For research use only.